Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Rami Fakih

Neurology Columbia, MO Medical Doctor

NPI 1124515994 CMS profile 5007683

1 Hospital Dr, Columbia, MO 65201

Open in the dashboard

General payments

$9,033

71 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rami Fakih of Columbia, MO is reported in the CMS Open Payments database as having received $9,033 across 71 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,304 52
2024 General $2,526 16
2023 General $164 2
2022 General $39 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rami Fakih
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Rami Fakih were reported at $6,304. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Rami Fakih Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $0 $367 $82–$2,309 $114
2021 $0 $438 $104–$2,547 $132
2022 $39 $442 $103–$2,388 $149
2023 $164 $464 $119–$2,312 $160
2024 $2,526 $468 $119–$2,323 $164
2025 $6,304 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Penumbra, Inc. $2,401 12 payments
  2. Medical Device Business Services, Inc. $2,194 18 payments
  3. Rapid Medical LTD $1,557 4 payments
  4. MicroVention, Inc. $1,332 16 payments
  5. Medtronic, Inc. $771 10 payments
  6. DePuy Synthes Sales Inc. $265 3 payments
  7. Route 92 Medical, Inc. $194 2 payments
  8. Imperative Care, INc $90 1 payment
  9. Qapel Medical Inc $77 1 payment
  10. Amgen Inc. $70 1 payment
  11. Other $82 3 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $6,333 26 payments
  2. Food and Beverage $2,700 45 payments
Products named General payments · program years 2022–2025
  1. Penumbra System $2,364 10 payments
  2. TRUFILL $2,034 16 payments
  3. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $1,557 4 payments
  4. COMANECI 17 $1,557 4 payments
  5. INTELLIS ADAPTIVESTIM $555 7 payments
  6. 8F BASE CAMP SHEATH SYSTEM $194 2 payments
  7. CEREBASE $144 1 payment
  8. TRACSTAR LARGE DISTAL PLATFORM $90 1 payment
  9. EMBOTRAP $79 1 payment
  10. REPATHA $70 1 payment
  11. Other $133 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

71 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record